Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.35
+0.55 (1.46%)
Aug 12, 2025, 1:00 PM CST
1.46%
Market Cap4.88B
Revenue (ttm)173.63M
Net Income (ttm)-281.94M
Shares Out129.09M
EPS (ttm)-2.19
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,577
Average Volume84,404
Open38.50
Previous Close37.80
Day's Range37.90 - 38.60
52-Week Range37.00 - 75.80
Beta0.44
RSI37.18
Earnings DateAug 10, 2025

About Theseus Pharmaceuticals

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, T... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.